These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1788106)

  • 21. Treatment of central precocious puberty: comparison of urinary gonadotropin excretion and gonadotropin-releasing hormone (GnRH) stimulation tests in monitoring GnRH analog therapy.
    Witchel SF; Baens-Bailon RG; Lee PA
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1353-6. PubMed ID: 8636332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Luteinizing Hormone Secretion during Gonadotropin-Releasing Hormone Stimulation Tests in Obese Girls with Central Precocious Puberty.
    Lee HS; Yoon JS; Hwang JS
    J Clin Res Pediatr Endocrinol; 2016 Dec; 8(4):392-398. PubMed ID: 27215137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gonadotrophin responses to GnRH in precocious puberty treated with GnRH analogue.
    Donaldson MD; Stanhope R; Lee TJ; Price DA; Brook CG; Savage DC
    Clin Endocrinol (Oxf); 1984 Nov; 21(5):499-503. PubMed ID: 6437705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of gonadotrophin suppression in girls treated with GnRH analogue for central precocious puberty; validity of single luteinizing hormone measurement after leuprolide acetate injection.
    Demirbilek H; Alikasifoglu A; Gonc NE; Ozon A; Kandemir N
    Clin Endocrinol (Oxf); 2012 Jan; 76(1):126-30. PubMed ID: 21790701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of central precocious puberty with an LHRH agonist (Buserelin): effect on growth and bone maturation after three years of treatment.
    Rappaport R; Fontoura M; Brauner R
    Horm Res; 1987; 28(2-4):149-54. PubMed ID: 2969858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversible inhibition of central precocious puberty with a long acting GnRH analogue.
    Ward PS; Ward I; McNinch AW; Savage DC
    Arch Dis Child; 1985 Sep; 60(9):872-4. PubMed ID: 3931565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum melatonin in central precocious puberty is lower than in age-matched prepubertal children.
    Waldhauser F; Boepple PA; Schemper M; Mansfield MJ; Crowley WF
    J Clin Endocrinol Metab; 1991 Oct; 73(4):793-6. PubMed ID: 1909703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of an ultrasensitive recombinant cell bioassay to determine estrogen levels in girls with precocious puberty treated with a luteinizing hormone-releasing hormone agonist.
    Klein KO; Baron J; Barnes KM; Pescovitz OH; Cutler GB
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2387-9. PubMed ID: 9661615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of local data to enhance uptake of published recommendations: an example from the diagnostic evaluation of precocious puberty.
    Harrington J; Palmert MR; Hamilton J
    Arch Dis Child; 2014 Jan; 99(1):15-20. PubMed ID: 24170688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25 mg).
    Carel JC; Lahlou N; Jaramillo O; Montauban V; Teinturier C; Colle M; Lucas C; Chaussain JL
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4111-6. PubMed ID: 12213857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of histrelin subdermal implant in children with central precocious puberty: a multicenter trial.
    Eugster EA; Clarke W; Kletter GB; Lee PA; Neely EK; Reiter EO; Saenger P; Shulman D; Silverman L; Flood L; Gray W; Tierney D
    J Clin Endocrinol Metab; 2007 May; 92(5):1697-704. PubMed ID: 17327379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of distinct activating mutations of the luteinizing hormone receptor gene on the pituitary-gonadal axis in both sexes.
    Latronico AC; Lins TS; Brito VN; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2000 Nov; 53(5):609-13. PubMed ID: 11106922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disorders of Puberty: An Approach to Diagnosis and Management.
    Klein DA; Emerick JE; Sylvester JE; Vogt KS
    Am Fam Physician; 2017 Nov; 96(9):590-599. PubMed ID: 29094880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LH-RH agonistic analog (buserelin) treatment of precocious puberty: collaborative study in Japan.
    Suwa S; Hibi I; Kato K; Nakazima H
    Acta Paediatr Jpn; 1988; 30 Suppl():176-84. PubMed ID: 3146872
    [No Abstract]   [Full Text] [Related]  

  • 35. High diagnostic accuracy of subcutaneous Triptorelin test compared with GnRH test for diagnosing central precocious puberty in girls.
    Freire AV; Escobar ME; Gryngarten MG; Arcari AJ; Ballerini MG; Bergadá I; Ropelato MG
    Clin Endocrinol (Oxf); 2013 Mar; 78(3):398-404. PubMed ID: 22845185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The treatment of central precocious puberty using an intranasal LHRH analogue (buserelin).
    Stanhope R; Adams J; Brook CG
    Clin Endocrinol (Oxf); 1985 Jun; 22(6):795-806. PubMed ID: 3926352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Random luteinizing hormone often remains pubertal in children treated with the histrelin implant for central precocious puberty.
    Lewis KA; Eugster EA
    J Pediatr; 2013 Mar; 162(3):562-5. PubMed ID: 23040793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Short-term comparison of the treatment of precocious puberty with 2 different LHRH antagonists (buserelin and long-acting triptorelin). An endocrinologic and echographic study].
    Cicognani A; Cacciari E; Balsamo A; Cassio A; Papasodero A; Bellizzi M; Guacci P; Zappulla F
    Pediatr Med Chir; 1994; 16(1):43-8. PubMed ID: 8029088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonadotropin and gonadal steroid release in response to a gonadotropin-releasing hormone agonist in Gqalpha and G11alpha knockout mice.
    Stanislaus D; Janovick JA; Ji T; Wilkie TM; Offermanns S; Conn PM
    Endocrinology; 1998 Jun; 139(6):2710-7. PubMed ID: 9607776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naloxone-induced luteinizing hormone secretion in normal, precocious, and delayed puberty.
    Petraglia F; Bernasconi S; Iughetti L; Loche S; Romanini F; Facchinetti F; Marcellini C; Genazzani AR
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1112-6. PubMed ID: 3531220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.